Aubert, Olivier
Divard, Gillian
Pascual, Julio
Oppenheimer, Federico
Sommerer, Claudia
Citterio, Franco
Tedesco, Helio
Chadban, Steve
Henry, Mitchell
Vincenti, Flavio
Srinivas, Titte
Watarai, Yoshihiko
Legendre, Christophe
Bernhardt, Peter
Loupy, Alexandre https://orcid.org/0000-0003-3388-7747
Clinical trials referenced in this document:
Documents that mention this clinical trial
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
https://doi.org/10.1681/asn.2018010009
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
https://doi.org/10.1136/bmjopen-2021-052138
Documents that mention this clinical trial
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
https://doi.org/10.1136/bmjopen-2021-052138
Documents that mention this clinical trial
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
https://doi.org/10.1136/bmjopen-2021-052138
Funding for this research was provided by:
Novartis Pharma (N/A)
Fondation Bettencourt Schueller (N/A)
French national research agency (N/A)